C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Takes $374,000 Position in The Clorox Company (NYSE:CLX)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,305 shares of the company's stock, valued at approximately $374,000.

Several other hedge funds have also modified their holdings of CLX. Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP lifted its position in Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock valued at $88,315,000 after buying an additional 453,624 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company's stock worth $877,390,000 after purchasing an additional 435,971 shares in the last quarter. Boston Trust Walden Corp lifted its position in shares of Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company's stock worth $44,622,000 after purchasing an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock worth $57,390,000 after purchasing an additional 265,455 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research analyst reports. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and lifted their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. Finally, Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of "Hold" and a consensus price target of $158.21.

Clorox Price Performance

Clorox stock traded up $3.46 during mid-day trading on Friday, hitting $156.53. 1,203,073 shares of the company were exchanged, compared to its average volume of 1,317,613. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The business has a fifty day moving average of $157.87 and a 200 day moving average of $159.63. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a market capitalization of $19.28 billion, a PE ratio of 42.73, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 earnings per share. As a group, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.